Surgery Partners Inc
NASDAQ:SGRY
Balance Sheet
Balance Sheet Decomposition
Surgery Partners Inc
Surgery Partners Inc
Balance Sheet
Surgery Partners Inc
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
13
|
75
|
58
|
70
|
175
|
184
|
93
|
318
|
390
|
283
|
196
|
270
|
|
| Cash Equivalents |
13
|
75
|
58
|
70
|
175
|
184
|
93
|
318
|
390
|
283
|
196
|
270
|
|
| Total Receivables |
56
|
154
|
198
|
230
|
302
|
308
|
336
|
382
|
430
|
456
|
496
|
579
|
|
| Accounts Receivables |
54
|
145
|
178
|
221
|
288
|
308
|
327
|
382
|
430
|
456
|
496
|
579
|
|
| Other Receivables |
1
|
9
|
20
|
10
|
14
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
5
|
24
|
26
|
29
|
45
|
43
|
46
|
56
|
61
|
71
|
75
|
88
|
|
| Other Current Assets |
10
|
17
|
30
|
33
|
41
|
53
|
51
|
45
|
65
|
110
|
128
|
182
|
|
| Total Current Assets |
83
|
269
|
311
|
362
|
563
|
588
|
526
|
802
|
946
|
921
|
895
|
1 119
|
|
| PP&E Net |
21
|
175
|
185
|
204
|
399
|
426
|
821
|
855
|
954
|
1 156
|
1 224
|
1 384
|
|
| PP&E Gross |
21
|
175
|
185
|
204
|
399
|
426
|
821
|
855
|
954
|
1 156
|
1 224
|
1 384
|
|
| Accumulated Depreciation |
17
|
56
|
70
|
86
|
20
|
56
|
111
|
189
|
272
|
374
|
454
|
554
|
|
| Intangible Assets |
27
|
55
|
54
|
48
|
59
|
54
|
47
|
47
|
44
|
42
|
55
|
46
|
|
| Goodwill |
340
|
1 299
|
1 408
|
1 555
|
3 347
|
3 383
|
3 402
|
3 468
|
3 912
|
4 137
|
4 326
|
5 068
|
|
| Note Receivable |
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
36
|
37
|
40
|
78
|
79
|
94
|
91
|
89
|
190
|
184
|
215
|
|
| Other Long-Term Assets |
4
|
25
|
110
|
95
|
175
|
146
|
129
|
152
|
174
|
236
|
193
|
58
|
|
| Other Assets |
340
|
1 299
|
1 408
|
1 555
|
3 347
|
3 383
|
3 402
|
3 468
|
3 912
|
4 137
|
4 326
|
5 068
|
|
| Total Assets |
475
N/A
|
1 859
+292%
|
2 104
+13%
|
2 305
+10%
|
4 623
+101%
|
4 676
+1%
|
5 019
+7%
|
5 413
+8%
|
6 118
+13%
|
6 682
+9%
|
6 877
+3%
|
7 890
+15%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
18
|
43
|
45
|
50
|
85
|
83
|
97
|
100
|
125
|
152
|
172
|
209
|
|
| Accrued Liabilities |
11
|
46
|
54
|
71
|
123
|
183
|
229
|
223
|
215
|
190
|
220
|
258
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
9
|
22
|
27
|
28
|
59
|
63
|
56
|
64
|
60
|
63
|
73
|
101
|
|
| Other Current Liabilities |
4
|
30
|
55
|
38
|
37
|
20
|
17
|
169
|
137
|
89
|
58
|
57
|
|
| Total Current Liabilities |
43
|
141
|
181
|
187
|
303
|
349
|
398
|
557
|
537
|
493
|
523
|
624
|
|
| Long-Term Debt |
419
|
1 390
|
1 282
|
1 467
|
2 252
|
2 421
|
2 525
|
2 792
|
2 878
|
2 559
|
2 702
|
3 269
|
|
| Deferred Income Tax |
16
|
49
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
|
| Minority Interest |
89
|
486
|
485
|
496
|
981
|
1 021
|
1 008
|
1 073
|
1 211
|
1 285
|
1 375
|
1 846
|
|
| Other Liabilities |
12
|
56
|
160
|
146
|
101
|
121
|
397
|
441
|
403
|
347
|
290
|
322
|
|
| Total Liabilities |
578
N/A
|
2 123
+267%
|
2 109
-1%
|
2 295
+9%
|
3 637
+58%
|
3 912
+8%
|
4 327
+11%
|
4 863
+12%
|
5 029
+3%
|
4 684
-7%
|
4 890
+4%
|
6 100
+25%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
1
|
1
|
331
|
360
|
396
|
435
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
163
|
322
|
321
|
311
|
41
|
247
|
316
|
432
|
503
|
557
|
569
|
737
|
|
| Additional Paid In Capital |
60
|
58
|
316
|
321
|
696
|
674
|
663
|
608
|
1 622
|
2 478
|
2 498
|
2 521
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
22
|
51
|
61
|
32
|
76
|
58
|
5
|
|
| Total Equity |
104
N/A
|
264
-155%
|
4
+98%
|
10
N/A
|
986
+10 060%
|
764
-22%
|
692
-9%
|
550
-20%
|
1 089
+98%
|
1 998
+83%
|
1 987
-1%
|
1 790
-10%
|
|
| Total Liabilities & Equity |
475
N/A
|
1 859
+292%
|
2 104
+13%
|
2 305
+10%
|
4 623
+101%
|
4 676
+1%
|
5 019
+7%
|
5 413
+8%
|
6 118
+13%
|
6 682
+9%
|
6 877
+3%
|
7 890
+15%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
48
|
48
|
48
|
49
|
49
|
49
|
49
|
51
|
89
|
126
|
127
|
127
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|